Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. 28 de jul. de 2009 · Faculty Profile. Home. Faculty Directory. Michael A. Brownlee, M.D. Professor Emeritus, Department of Medicine (Endocrinology) Professor Emeritus, Department of Pathology. Anita and Jack Saltz Chair in Diabetes Research Emeritus. Contact Information. 718.430.2753 michael.brownlee@einsteinmed.edu.

  2. Michael BROWNLEE, Anita and Jack Saltz Professor of Diabetes Research | Cited by 71,261 | of Albert Einstein College of Medicine, NY (AECOM) | Read 248 publications | Contact Michael...

  3. 9 de ene. de 2014 · Brownlee is professor of medicine and of pathology at Einstein. He holds the Anita and Jack Saltz Chair in Diabetes Research and is associate director for biomedical sciences in Einstein’s Diabetes Research Center .

  4. Research Briefs. Michael Brownlee. Chain of Events — Diabetes causes nerve damage—“diabetic neuropathy”—in the majority of people with this disease. Painful diabetic neuropathy is the most incapacitating neuropathy syndrome. A paper in the May 13 issue of Nature Medicine describes for the first time the molecular chain of events ...

  5. Hacia fines del 2001, Michael Brownlee, basándo-se en investigaciones propias y de otro autores12, concluyó que la vía común que conducía a todas las complicaciones restantes conocidas era la excesiva producción de radicales libres de oxígeno en la cadena respiratoria mitocondrial la que se veía sobresaturada por el aflujo masivo de precur-

  6. Michael Brownlee 1. Affiliation. 1 Departments of Medicine and Pathology, Albert Einstein College of Medicine, F-531 1300 Morris Park Ave., Bronx, NY 10461-1602, USA. brownlee@aecom.yu.edu. PMID: 15919781. DOI: 10.2337/diabetes.54.6.1615. Publication types. Lecture. Research Support, N.I.H., Extramural. Research Support, Non-U.S. Gov't.

  7. 29 de oct. de 2010 · Overexpression of superoxide dismutase in transgenic diabetic mice prevents diabetic retinopathy, nephropathy, and cardiomyopathy. The aim of this review is to highlight advances in understanding the role of metabolite-generated ROS in the development of diabetic complications.